Page: Viewing Company


Viewing Company


Company Name: ImmunoPrecise Antibodies Ltd.
CIK: 1715925
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2021-09-29
Last Filing Date: 2025-03-28

SEC Filings
Start End Frame Filed ACCN Value View
2020-05-01 2021-04-30 CY2019 2021-09-29 0001564590-21-049295 $ 16,474,350 View
2021-05-01 2022-04-30 CY2020 2022-07-29 0001193125-22-205824 $ 10 View
2023-08-01 2023-10-31 CY2023Q3I 2024-02-15 0001062993-24-003282 $ 1,400,000 View
2023-05-01 2024-04-30 CY2023 2024-07-29 0000950170-24-087127 $ 24,518,000 View
2024-05-01 2024-07-31 CY2024Q2I 2024-09-16 0000950170-24-106621 $ 2,599,000 View
2024-08-01 2024-10-31 CY2024Q3I 2024-12-10 0000950170-24-134774 $ 3,093,000 View
2024-05-01 2025-01-31 CY2024Q4 2025-03-28 0000950170-25-046368 $ 21,184,000 View
2022-05-01 2023-04-30 CY2022 2023-07-10 0000950170-23-032388 $ 19,812,000 View
2023-11-01 2024-01-31 CY2023Q4 2024-03-14 0000950170-24-031153 $ 4,178,000 View
SEC Facts By Type
Type Name Description View
ifrs-full 2365381 None View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
Chart of Accounts => Accounts
Name View
General and Administrative Expense View